Literature DB >> 17107720

Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability?

Mario Curione, Claudio Letizia, Silvia Amato, Simonetta Di Bona, Fabio Di Fazio, Salvatore Minisola, Gianfranco Mazzuoli, Emilio D'Erasmo.   

Abstract

BACKGROUND: Increased risk of death in patients with primary hyperparathyroidism (PHPT) is referred to cardiovascular complications induced by hypercalcemia. At the moment the role of bioelectrical risk and of enhanced sympathetic activity, not related to cardiovascular complications, is unknown in PHPT patients.
METHODS: The study was designed to evaluate the QT parameters and sympathovagal balance in 28 PHPT uncomplicated patients compared to 29 healthy subjects (HS). Nine of 28 patients were restudied after parathyroidectomy. Standard ECG, short and 24-h ECG monitoring were performed to calculate QT parameters and Heart Rate Variability (HRV).
RESULTS: QTc interval resulted shorter in PHPT patients than in HS and QTc dispersion resulted higher in PHPT patients than HS. The physiological adaptation of QT length to R-R interval was lacking in PHPT patients. Enhanced sympathetic tone was found in PTHP patients than controls. These data were confirmed after parathyroidectomy.
CONCLUSION: Our findings revealed an increased risk to develop life-threatening arrhythmias in PHPT patients due to bioelectrical instability induced by hypercalcemia. Parathyroidectomy doesn't seem to reverse this abnormality.

Entities:  

Mesh:

Year:  2006        PMID: 17107720     DOI: 10.1016/j.ijcard.2006.08.072

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

Review 2.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

Review 3.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

4.  Acute effect of zoledronic acid on the risk of cardiac dysrhythmias.

Authors:  Cristiana Cipriani; Claudia Castro; Mario Curione; Sara Piemonte; Federica Biamonte; Claudio Savoriti; Jessica Pepe; Federica De Lucia; Carolina Clementelli; Luciano Nieddu; Salvatore Minisola
Journal:  Intern Emerg Med       Date:  2014-09-05       Impact factor: 3.397

Review 5.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

6.  Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results.

Authors:  Petramala Luigi; Formicuccia Maria Chiara; Zinnamosca Laura; Marinelli Cristiano; Cilenti Giuseppina; Colangelo Luciano; Panzironi Giuseppe; Cerci Sabrina; Sciomer Susanna; Ciardi Antonio; Cavallaro Giuseppe; De Toma Giorgio; Letizia Claudio
Journal:  Int J Endocrinol       Date:  2012-06-07       Impact factor: 3.257

7.  Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts.

Authors:  Gary Tse; Bing Sun; Sheung Ting Wong; Vivian Tse; Jie Ming Yeo
Journal:  Biomed Rep       Date:  2016-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.